510(k) K033364
K033364 is an FDA 510(k) premarket notification submitted by Chad Therapeutics, Inc. for the device "CHAD THERAPEUTICS SAGE". The FDA issued a decision of Substantially Equivalent on May 11, 2004. The device falls under product code NFB (Conserver, Oxygen), a Class II device regulated under 21 CFR 868.5905. Chad Therapeutics, Inc. has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- May 11, 2004
- Date Received
- October 21, 2003
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Conserver, Oxygen
- Device Class
- Class II
- Regulation Number
- 868.5905
- Review Panel
- AN
- Submission Type